KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Prepaid Assets (2024 - 2025)

Novartis Ag (NVS) has disclosed Prepaid Assets for 2 consecutive years, with $1.2 billion as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 17.06% to $1.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 billion through Dec 2025, up 17.06% year-over-year, with the annual reading at $1.2 billion for FY2025, 17.06% up from the prior year.
  • Prepaid Assets hit $1.2 billion in Q4 2025 for Novartis Ag, up from $985.0 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $1.2 billion in Q4 2025 to a low of $985.0 million in Q4 2024.